Sign In
18 Jun 2012 07:00
ο»Ώ
Β
18 June 2012
Β
TYRATECH, INC.
("TyraTech" or the "Company")
Β
Block Listing Interim Review
Β
TyraTech, Inc. (AIM: TYR), a natural life sciences company, provides the following information in connection with its block admission pursuant to AIM Rule 29 and Schedule Six of the AIM Rules:
Β
Β
Name of company: | TyraTech, Inc. Β |
Name of scheme: | 2007 Equity Compensation Plan of the Company Β |
Period of return: | From: 8 December 2011 To: 17 June 2012 Β |
Number and class of securities not issued under the scheme at the start of the period | 5,164,996 common shares Β Β |
Number of securities issued under the scheme during the period | 18,750 Β Β |
Balance under the scheme of securities not yet issued at the end of the period | 5,146,246 common shares Β Β |
Number and class of securities originally admitted and the date of admission | 5,183,746 common shares on 2 March 2011 Β Β |
Name of contact: | Peter Jerome Β |
Telephone number of contact: | +1 919 415 4280 |
Β
Β
Β
For further information please contact:
Β
TyraTech Inc. Alan Reade, Executive Chairman Peter Jerome, Chief Financial Officer Β | Β Tel: +1 919 415 4310 Tel: +1 919 415 4280 |
N+1 Brewin, Nominated Adviser and Joint Broker Aubrey Powell / Robert Beenstock / Alex Wright Β | Tel: +44 20 3201 3170 |
First Columbus LLP, Joint Broker ChrisΒ Crawford Β | Tel: +44 20 3002 2070 |
Β
Follow the stocks
